Yum Brands Q3: EPS Beat, Revenue Miss—Is YUM a Sell?
💡 Key Takeaway
Yum Brands beat EPS estimates but missed revenue, with weak divisional performance and a Zacks Rank #5, suggesting near-term underperformance.
Yum's Q3: A Mixed Bag with Revenue Shortfall
Yum Brands reported third-quarter earnings that were a mixed bag. The company beat earnings per share (EPS) expectations, but revenue fell short of analyst consensus. This top-line miss is concerning because it indicates that sales growth is not as robust as expected.
Several divisional revenues also came in below estimates, and franchise contribution revenues declined year-over-year. This suggests underlying operational challenges despite modest overall growth. The revenue miss is particularly noteworthy because it contrasts with the EPS beat, which may have been driven by cost-cutting or other non-revenue factors.
Investors should note that revenue is a key indicator of a company's health, especially for a franchisor like Yum, where franchise fees and royalties are tied to system sales. A decline in franchise contributions could signal weakness in the underlying business.
Additionally, Yum received a Zacks Rank #5 (Strong Sell), which indicates expected underperformance relative to the broader market. This rating is based on factors like earnings estimate revisions and is a bearish signal for the stock.
Overall, while the EPS beat is positive, the revenue miss and weak divisional performance raise red flags about Yum's growth trajectory.
What This Means for Me
Why the Revenue Miss Matters for YUM Stock
The revenue miss is significant because it suggests that Yum's growth may be slowing. In the restaurant industry, revenue growth is closely tied to same-store sales and new unit openings. If revenue is missing estimates, it could mean that these metrics are underperforming.
Moreover, the decline in franchise contribution revenues is a concern because Yum's business model relies heavily on franchising. Franchise fees and royalties are high-margin revenue streams, and a decline here could pressure profitability.
The Zacks Rank #5 is a strong negative signal. This rank is based on a combination of factors, including earnings estimate revisions, and it has a track record of predicting underperformance. Investors often use such ratings as a sell signal.
For the stock price, the revenue miss and the strong sell rating could lead to downward pressure in the near term. The market may react negatively to the top-line miss, especially if it's seen as a sign of broader operational issues.
Looking ahead, Yum's ability to reignite revenue growth and improve franchise contributions will be key. If the company can address these challenges, the stock could recover, but for now, the outlook is cautious.
Stock to Watch
| Stocks | Impact | Analysis | |
|---|---|---|---|
| YUM | Negative | Revenue miss and Zacks Rank #5 suggest near-term underperformance, with weak divisional revenues and declining franchise contributions. |
Source: Zacks Investment Research
Analysis generated by Bobby AI quantitative model, reviewed and edited by our research team. This is not financial advice. Always do your own research before making investment decisions.
Bobby Insight

Avoid YUM for now; wait for clearer signs of revenue growth and operational improvement.
The revenue miss and strong sell rating are red flags that could pressure the stock. While the EPS beat is positive, it's overshadowed by top-line weakness and declining franchise revenues. Until Yum shows sustained revenue growth, the risk/reward is unfavorable.
What This Means for Me

Read More
Novo Nordisk: Wegovy Pill Sales Strong, But Is NVO a Buy?
Bullish Novo Nordisk's successful Wegovy pill launch supports its high-volume/low-price strategy, and with the stock down 70% and a 4.4% dividend yield, the risk/reward looks favorable for value and income investors.
NVOLLYAMJBJPMNov 12, 2026International Paper: 3 Key Takeaways for Long-Term Investors
Bullish International Paper is gaining market share and cutting costs effectively, positioning itself for long-term growth despite near-term demand headwinds.
IPNov 12, 2026Caesarstone Q3: Margin Gains Marred by $46.8M Legal Verdict
Bearish Caesarstone's operational turnaround is real, but the $46.8 million silica verdict introduces significant financial uncertainty that overshadows near-term progress.
CSTENov 12, 2026

